XML 120 R105.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Quarterly Financial Data - Unaudited - Consolidated Statements of Changes in Stockholder's Equity / (Deficit) (Detail) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Jun. 30, 2023
Mar. 31, 2023
Mar. 06, 2023
Sep. 30, 2022
Jul. 10, 2022
Jun. 30, 2022
Jun. 10, 2022
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Aug. 25, 2020
Oct. 31, 2018
Beginning Balance   $ (70,648,430) $ (88,674,942) $ (66,992,873)                        
Share-based compensation   166,069 585,654 1,811,551                        
Common stock issued for warrants exercised   303,349 303,349                          
Common stock issued for exercise of warrant , Shares             3,703,703   4,939,515   90,552 28,363   551,378 1,873,622 700,000
Fair value of warrants issued $ 2,381,004 390,809 3,926,962                          
Net income / (loss)   (6,052,860) (3,884,602) (29,822,431)                        
Ending Balance $ (85,906,534) (75,841,063) (85,906,534) (88,674,942)                        
Previously Reported [Member]                                
Stockholders' deficit         $ (65,017,481) $ (57,453,484)   $ (70,944,274)   $ (63,853,295)   $ (72,445,582) $ (62,488,638)      
Beginning Balance   (65,017,481) (76,544,758) (62,488,638)                        
Net income / (loss)       (30,883,322)                        
Ending Balance       (76,544,758)                        
Litigation Financing Adjustment [Member]                                
Stockholders' deficit       1,844,260 3,902,384 2,322,725   (812,244)   (3,462,754)   (3,005,466) (4,001,135)      
Beginning Balance   3,902,384                            
Net income / (loss)       5,845,395                        
Other Adjustments [Member]                                
Stockholders' deficit       131,123 916,712 627,408   0   0   (311,123) 0      
Beginning Balance   916,712                            
Net income / (loss)       131,123                        
2022 Warrant Adjustment [Member]                                
Stockholders' deficit         (9,946,945) (8,870,064)   (10,436,569)   (11,648,889)            
Beginning Balance   (9,946,945)                            
Investment in Unconsolidated Entities Adjustments [Member]                                
Stockholders' deficit         (503,100) (503,100)   (503,100)   (503,100)   (503,100) (503,100)      
Beginning Balance   (503,100)                            
Restated [Member]                                
Stockholders' deficit         (70,648,430) (63,876,515)   (82,696,187)   (79,468,038)   (76,265,271) (66,992,873)      
Beginning Balance   (70,648,430)                            
Revision of Prior Period, Adjustment [Member]                                
Stockholders' deficit         $ (5,630,949) (6,423,031)   (11,751,913)   (15,614,743)   (3,819,689) (4,504,235)      
Common Stock [Member]                                
Beginning Balance   $ 1,998 $ 1,954 $ 1,431                        
Beginning Balance, Shares   19,981,901 19,540,310 14,309,315                        
Common stock issued for warrants exercised   $ 9 $ 9                          
Common stock issued for exercise of warrant , Shares 90,552   90,552   90,552                      
Ending Balance $ 2,042 $ 2,007 $ 2,042 $ 1,954                        
Ending Balance, Shares 20,420,896 20,072,453 20,420,896 19,540,310                        
Common Stock [Member] | Previously Reported [Member]                                
Stockholders' deficit         $ 1,998 $ 1,989   $ 1,950   $ 1,946   $ 1,448 $ 1,431      
Stockholders' deficit, Shares         19,981,901 19,893,450   19,507,469   19,464,950   14,487,146 14,309,315      
Beginning Balance     $ 1,954 $ 1,431                        
Beginning Balance, Shares     19,540,310 14,309,315                        
Ending Balance       $ 1,954                        
Ending Balance, Shares       19,540,310                        
Common Stock [Member] | Litigation Financing Adjustment [Member]                                
Stockholders' deficit       $ 0                        
Stockholders' deficit, Shares       0                        
Common Stock [Member] | Other Adjustments [Member]                                
Stockholders' deficit       $ 0                        
Stockholders' deficit, Shares       0                        
Common Stock [Member] | Restated [Member]                                
Stockholders' deficit         $ 1,998 $ 1,989   $ 1,950   $ 1,946   $ 1,448 $ 1,431      
Stockholders' deficit, Shares         19,981,901 19,893,450   19,507,469   19,464,950   14,487,146 14,309,315      
Additional Paid-in Capital [Member]                                
Beginning Balance   $ 262,164,455 $ 256,963,264 $ 248,823,425                        
Share-based compensation   166,069 585,654 1,811,551                        
Common stock issued for warrants exercised   303,340 303,340                          
Fair value of warrants issued   390,809 3,926,962                          
Ending Balance $ 263,616,186 263,024,673 263,616,186 256,963,264                        
Additional Paid-in Capital [Member] | Previously Reported [Member]                                
Stockholders' deficit         $ 271,083,470 $ 270,608,427   $ 264,621,682   $ 264,323,108   $ 249,189,881 $ 249,055,600      
Beginning Balance     265,882,279 249,055,600                        
Ending Balance       265,882,279                        
Additional Paid-in Capital [Member] | Litigation Financing Adjustment [Member]                                
Stockholders' deficit       0 0                      
Additional Paid-in Capital [Member] | Other Adjustments [Member]                                
Stockholders' deficit       (232,175) (232,175) (232,175)   (232,175)   (232,175)   (232,175) (232,175)      
Additional Paid-in Capital [Member] | 2022 Warrant Adjustment [Member]                                
Stockholders' deficit         (8,686,840) (8,686,840)   (8,686,840)   (8,686,840)            
Additional Paid-in Capital [Member] | Investment in Unconsolidated Entities Adjustments [Member]                                
Stockholders' deficit         0 0   0   0   0 0      
Additional Paid-in Capital [Member] | Restated [Member]                                
Stockholders' deficit         262,164,455 261,689,412   255,702,667   255,404,093   248,957,706 248,823,425      
Additional Paid-in Capital [Member] | Revision of Prior Period, Adjustment [Member]                                
Stockholders' deficit         (8,919,015) (8,919,015)   (8,919,015)   (8,919,015)   (232,175) (232,175)      
Accumulated Deficit [Member]                                
Beginning Balance   (284,066,697) (301,442,776) (279,362,917)                        
Net income / (loss)   (3,813,287) 5,345,819 (22,079,859)                        
Ending Balance (296,096,957) (287,879,984) (296,096,957) (301,442,776)                        
Accumulated Deficit [Member] | Previously Reported [Member]                                
Stockholders' deficit         (287,354,763) (281,631,073)   (293,459,800)   (288,004,571)   (283,321,086) (275,090,857)      
Beginning Balance     (298,231,607) (275,090,857)                        
Ending Balance       (298,231,607)                        
Accumulated Deficit [Member] | Litigation Financing Adjustment [Member]                                
Stockholders' deficit       1,844,260 3,902,384 2,322,725   (812,244)   (3,462,754)   (3,005,466) (4,001,135)      
Accumulated Deficit [Member] | Other Adjustments [Member]                                
Stockholders' deficit       363,298 1,148,887 859,583   232,175   232,175   (78,948) 232,175      
Accumulated Deficit [Member] | 2022 Warrant Adjustment [Member]                                
Stockholders' deficit         (1,260,105) (183,224)   (1,749,729)   (2,962,049)            
Accumulated Deficit [Member] | Investment in Unconsolidated Entities Adjustments [Member]                                
Stockholders' deficit         (503,100) (503,100)   (503,100)   (503,100)   (503,100) (503,100)      
Accumulated Deficit [Member] | Restated [Member]                                
Stockholders' deficit         (284,066,697) (279,135,089)   (296,292,698)   (294,700,299)   (286,908,600) (279,362,917)      
Accumulated Deficit [Member] | Revision of Prior Period, Adjustment [Member]                                
Stockholders' deficit         3,288,066 2,495,984   (2,832,898)   (6,695,728)   (3,587,514) (4,272,060)      
Noncontrolling Interest [Member]                                
Beginning Balance   (48,748,186) (44,197,384) (36,454,812)                        
Net income / (loss)   (2,239,573) (9,230,421) (7,742,572)                        
Ending Balance $ (53,427,805) $ (50,987,759) (53,427,805) (44,197,384)                        
Noncontrolling Interest [Member] | Previously Reported [Member]                                
Stockholders' deficit         (48,748,186) (46,432,827)   (42,108,106)   (40,173,778)   (38,315,825) (36,454,812)      
Beginning Balance     $ (44,197,384) (36,454,812)                        
Ending Balance       (44,197,384)                        
Noncontrolling Interest [Member] | Litigation Financing Adjustment [Member]                                
Stockholders' deficit       0                        
Noncontrolling Interest [Member] | Other Adjustments [Member]                                
Stockholders' deficit       $ 0                        
Noncontrolling Interest [Member] | Restated [Member]                                
Stockholders' deficit         $ (48,748,186) $ (46,432,827)   $ (42,108,106)   $ (40,173,778)   $ (38,315,825) $ (36,454,812)